Gulf Pharmaceutical Industries PSC (JULPHAR) – Strategy, SWOT and Corporate Finance Report

Gulf Pharmaceutical Industries PSC (JULPHAR) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company which manufactures and distributes medicines in the Middle East and North Africa region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, gastro care, cardiopulmonary care and pain management and consumer care products. The company has manufacturing facilities in Ethiopia, Bangladesh, and Saudi Arabia. Julphar has offices in Asia, Middle East and Africa and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Scope

• Detailed information on Gulf Pharmaceutical Industries PSC required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Gulf Pharmaceutical Industries PSC in the form of a SWOT analysis

• An in-depth view of the business model of Gulf Pharmaceutical Industries PSC including a breakdown and examination of key business segments

• News about Gulf Pharmaceutical Industries PSC, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Gulf Pharmaceutical Industries PSC and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Gulf Pharmaceutical Industries PSC as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Gulf Pharmaceutical Industries PSCs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Barakat Pharmaceutical Industries

Abdi Ibrahim Ilac Sanayi ve Ticaret AS

Yiaco Medical Co

Globalpharma Co LLC

Neopharma LLC

Aburaihan Pharmaceutical Co

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Gulf Pharmaceutical Industries PSC - Key Facts

Gulf Pharmaceutical Industries PSC - Key Employees

Gulf Pharmaceutical Industries PSC - Key Employee Biographies

Gulf Pharmaceutical Industries PSC - Major Products and Services

Gulf Pharmaceutical Industries PSC - History

Gulf Pharmaceutical Industries PSC - Company Statement

Gulf Pharmaceutical Industries PSC - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Gulf Pharmaceutical Industries PSC - Business Description

Business Segment: Manufacturing

Performance

Business Segment: Planet

Performance

Geographical Segment: Oman

Performance

Geographical Segment: Others

Performance

Geographical Segment: Saudi Arabia

Performance

Geographical Segment: UAE

Performance

R&D Overview

Gulf Pharmaceutical Industries PSC - SWOT Analysis

SWOT Analysis - Overview

Gulf Pharmaceutical Industries PSC - Strengths

Gulf Pharmaceutical Industries PSC - Weaknesses

Gulf Pharmaceutical Industries PSC - Opportunities

Gulf Pharmaceutical Industries PSC - Threats

Gulf Pharmaceutical Industries PSC - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Gulf Pharmaceutical Industries PSC, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 15, 2023: Gulf Pharmaceutical Industries Julphar reports financial results for Q1 2023

May 17, 2022: Gulf Pharmaceutical Industries Julphar announces Q1 2022 results and delivers robust top and bottom line growth

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Gulf Pharmaceutical Industries PSC, Key Facts

Gulf Pharmaceutical Industries PSC, Key Employees

Gulf Pharmaceutical Industries PSC, Key Employee Biographies

Gulf Pharmaceutical Industries PSC, Major Products and Services

Gulf Pharmaceutical Industries PSC, History

Gulf Pharmaceutical Industries PSC, Subsidiaries

Gulf Pharmaceutical Industries PSC, Key Competitors

Gulf Pharmaceutical Industries PSC, Ratios based on current share price

Gulf Pharmaceutical Industries PSC, Annual Ratios

Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont…1)

Gulf Pharmaceutical Industries PSC, Annual Ratios (Cont…2)

Gulf Pharmaceutical Industries PSC, Interim Ratios

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Gulf Pharmaceutical Industries PSC, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Gulf Pharmaceutical Industries PSC, Performance Chart (2018 – 2022)

Gulf Pharmaceutical Industries PSC, Ratio Charts

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports